159 related articles for article (PubMed ID: 30628717)
1. Introduction of exogenous wild‑type p53 mediates the regulation of oncoprotein 18/stathmin signaling via nuclear factor‑κB in non‑small cell lung cancer NCI‑H1299 cells.
Chen S; Zhao Y; Shen F; Long D; Yu T; Lin X
Oncol Rep; 2019 Mar; 41(3):2051-2059. PubMed ID: 30628717
[TBL] [Abstract][Full Text] [Related]
2. In vitro neutralization of autocrine IL‑10 affects Op18/stathmin signaling in non‑small cell lung cancer cells.
Zhao Y; Chen S; Shen F; Long D; Yu T; Wu M; Lin X
Oncol Rep; 2019 Jan; 41(1):501-511. PubMed ID: 30320402
[TBL] [Abstract][Full Text] [Related]
3. Regulation of Oncoprotein 18/Stathmin Signaling by ERK Concerns the Resistance to Taxol in Nonsmall Cell Lung Cancer Cells.
Lin X; Liao Y; Chen X; Long D; Yu T; Shen F
Cancer Biother Radiopharm; 2016 Mar; 31(2):37-43. PubMed ID: 26881937
[TBL] [Abstract][Full Text] [Related]
4. The Cdc2/Cdk1 inhibitor, purvalanol A, enhances the cytotoxic effects of taxol through Op18/stathmin in non-small cell lung cancer cells in vitro.
Chen X; Liao Y; Long D; Yu T; Shen F; Lin X
Int J Mol Med; 2017 Jul; 40(1):235-242. PubMed ID: 28534969
[TBL] [Abstract][Full Text] [Related]
5. Vinblastine differs from Taxol as it inhibits the malignant phenotypes of NSCLC cells by increasing the phosphorylation of Op18/stathmin.
Shen F; Long D; Yu T; Chen X; Liao Y; Wu Y; Lin X
Oncol Rep; 2017 Apr; 37(4):2481-2489. PubMed ID: 28259950
[TBL] [Abstract][Full Text] [Related]
6. Silencing Op18/stathmin by RNA Interference Promotes the Sensitivity of Nasopharyngeal Carcinoma Cells to Taxol and High-Grade Differentiation of Xenografted Tumours in Nude Mice.
Lin X; Yu T; Zhang L; Chen S; Chen X; Liao Y; Long D; Shen F
Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):611-620. PubMed ID: 27289016
[TBL] [Abstract][Full Text] [Related]
7. RNAi targeting STMN alleviates the resistance to taxol and collectively contributes to down regulate the malignancy of NSCLC cells in vitro and in vivo.
Long D; Yu T; Chen X; Liao Y; Lin X
Cell Biol Toxicol; 2018 Feb; 34(1):7-21. PubMed ID: 28589243
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effects of Tubeimoside-1 in NCI-H1299 cells are mediated by microRNA-126-5p-induced inactivation of VEGF-A/VEGFR-2/ERK signaling pathway.
Shi H; Bi H; Sun X; Dong H; Jiang Y; Mu H; Liu G; Kong W; Gao R; Su J
Mol Med Rep; 2018 Mar; 17(3):4327-4336. PubMed ID: 29363720
[TBL] [Abstract][Full Text] [Related]
9. Op18/stathmin is involved in the resistance of taxol among different epithelial carcinoma cell lines.
Lin X; Liao Y; Xie J; Liu S; Su L; Zou H
Cancer Biother Radiopharm; 2014 Nov; 29(9):376-86. PubMed ID: 25379611
[TBL] [Abstract][Full Text] [Related]
10. Cell-cycle-regulated phosphorylation of oncoprotein 18 on Ser16, Ser25 and Ser38.
Brattsand G; Marklund U; Nylander K; Roos G; Gullberg M
Eur J Biochem; 1994 Mar; 220(2):359-68. PubMed ID: 8125092
[TBL] [Abstract][Full Text] [Related]
11. EBV-encoded LMP1 regulates Op18/stathmin signaling pathway by cdc2 mediation in nasopharyngeal carcinoma cells.
Lin X; Liu S; Luo X; Ma X; Guo L; Li L; Li Z; Tao Y; Cao Y
Int J Cancer; 2009 Mar; 124(5):1020-7. PubMed ID: 19048596
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-encoded LMP1 triggers regulation of the ERK-mediated Op18/stathmin signaling pathway in association with cell cycle.
Lin X; Tang M; Tao Y; Li L; Liu S; Guo L; Li Z; Ma X; Xu J; Cao Y
Cancer Sci; 2012 Jun; 103(6):993-9. PubMed ID: 22417000
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous nuclear ribonucleoprotein A2/B1 regulates the ERK and p53/HDM2 signaling pathways to promote the survival, proliferation and migration of non‑small cell lung cancer cells.
Kim MK; Choi MJ; Lee HM; Choi HS; Park YK; Ryu CJ
Oncol Rep; 2021 Aug; 46(2):. PubMed ID: 34109989
[TBL] [Abstract][Full Text] [Related]
14. Rsf-1 Influences the Sensitivity of Non-Small Cell Lung Cancer to Paclitaxel by Regulating NF-κB Pathway and Its Downstream Proteins.
Chen X; Sun X; Guan J; Gai J; Xing J; Fu L; Liu S; Shen F; Chen K; Li W; Han L; Li Q
Cell Physiol Biochem; 2017; 44(6):2322-2336. PubMed ID: 29258089
[TBL] [Abstract][Full Text] [Related]
15. Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis.
Singer S; Ehemann V; Brauckhoff A; Keith M; Vreden S; Schirmacher P; Breuhahn K
Hepatology; 2007 Sep; 46(3):759-68. PubMed ID: 17663418
[TBL] [Abstract][Full Text] [Related]
16. p53-mediated negative regulation of stathmin/Op18 expression is associated with G(2)/M cell-cycle arrest.
Johnsen JI; Aurelio ON; Kwaja Z; Jörgensen GE; Pellegata NS; Plattner R; Stanbridge EJ; Cajot JF
Int J Cancer; 2000 Dec; 88(5):685-91. PubMed ID: 11072234
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of stathmin expression is mediated directly by Egr1 and associated with p53 activity in lung cancer cell line A549.
Fang L; Min L; Lin Y; Ping G; Rui W; Ying Z; Xi W; Ting H; Li L; Ke D; Jihong R; Huizhong Z
Cell Signal; 2010 Jan; 22(1):166-73. PubMed ID: 19786090
[TBL] [Abstract][Full Text] [Related]
18. 7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway.
Hsu TS; Chen C; Lee PT; Chiu SJ; Liu HF; Tsai CC; Chao JI
Cancer Chemother Pharmacol; 2008 Oct; 62(5):799-808. PubMed ID: 18193228
[TBL] [Abstract][Full Text] [Related]
19. Oncoprotein 18 overexpression increases the sensitivity to vindesine in the human lung carcinoma cells.
Nishio K; Nakamura T; Koh Y; Kanzawa F; Tamura T; Saijo N
Cancer; 2001 Apr; 91(8):1494-9. PubMed ID: 11301397
[TBL] [Abstract][Full Text] [Related]
20. Serine 16 of oncoprotein 18 is a major cytosolic target for the Ca2+/calmodulin-dependent kinase-Gr.
Marklund U; Larsson N; Brattsand G; Osterman O; Chatila TA; Gullberg M
Eur J Biochem; 1994 Oct; 225(1):53-60. PubMed ID: 7925472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
